Global Automated Cell Counters Market To Record Protruding Growth With US$ 6,391.0 Million By 2028
Published date - 22/12/2022
December 2022 | Report Format: Electronic (PDF)
The prevalence of chronic and infectious diseases like cancer, AIDS, sepsis, malaria, influenza, measles, cholera, and vector-borne illnesses like chikungunya and polio is rising, which is driving growth in the global automated cell counting market. The demand for automated cell counting will increase as more serious diseases require cell counting for diagnosis and treatment. According to predictions from the Globe Health Organization (WHO), there will be about 37.7 million HIV-positive people in the world by the end of 2020, or in November 2021. Additionally, according to the same source, 680,000 people passed away in 2020 as a result of HIV-related causes. It is therefore expected that the incidence of infectious diseases will significantly speed up market expansion.
Due to the expensive cost of the apparatus, equipment, and procedures, people are unwilling to invest money in cell counting methods for medical or research purposes. Additionally, in developing countries, outdated technology and underdeveloped healthcare infrastructure are barriers to the expansion of automated cell counting. Additionally, the market for automated cell counting is being constrained by a lack of qualified specialists. Long-term market expansion will be hampered by the acute shortage of skilled labour and doctors in the healthcare industry.
North America holds the biggest share of the Automated Cell Counters Industry. The largest market share in the area is held by the US. Automated cell counter use is rising due to a number variables, including technology development and a sizable senior population predisposed to chronic illness. In the US, 1.2 million persons with HIV, according to the US Department of Health & Human Services. In addition, 36,801 people were given an HIV diagnosis in the US, and there were reported to be 34,800 additional HIV infections. CD4 cell counts are used to determining the disease stage and track antiviral therapy in HIV infection. The Healthy People 2030 initiative is raising awareness of the importance of providing preventative care for people of all ages, according to the Department of Health and Human Services. Blood testing, regular health checkups, and screenings are taught to children, adults, and the elderly. Therefore, the US market for automated cell counters is anticipated to grow as a result of government initiatives for preventative health care.
Request a Free Sample Copy: Automated Cell Counters Market Report
Automated Cell Counters Market Report Highlights
- In April 2021, launched Centrifuge 5910 Ri", designed to increase laboratory efficiency and to accelerate the centrifugation steps.
- In August 2019, Agilent Technologies acquired Biotek Instruments for expanding Agilent's presence and expertise in cell analysis and strengthen immuno-oncology and immunotherapy areas.
- In May 2021, Bio-Rad Laboratories partnered with major diagnostic companies such as Roche by offering InteliQ products, and a range of barcoded, load-and-go quality control tubes.
- In August 2022, DeNovix launches nuclei counting apps for CellDrop Automated Cell Counters
AUTOMATED CELL COUNTERS MARKET SEGMENTATION
The research report published by Market Research Strategy contains industry segments, as below-
Automated Cell Counters Product Type Outlook (Revenue, USD Million, 2017 - 2028)
- Systems Type
- Reagents & Consumables
Automated Cell Counters Application Outlook (Revenue, USD Million, 2017 - 2028)
- Blood Analysis
- Urine Analysis
- Microbial Cell Count
- Cell Line Viability
- Others
Automated Cell Counters Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)
List of Key Players- Automated Cell Counters Market
- Danaher Corporation
- Biotek Instruments, Inc.
- Alere Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd
- ChemoMetec A/S
- Logos Biosystems
- Beckman Coulter, Inc.
- NanoEnTek Inc.
- Olympus Corporation
About Market Research Strategy:
Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.
MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.
Contact Us:
Market Research Strategy
473 Mundet Place,
Ste US520501 Hillside
New Jersey 07205 United States
USA Phone: +1 9176726599
Business Email: sales@marketresearchstrategy.com
Website: https://marketresearchstrategy.com/